3Indexed trials
drug · Product Intelligence
Ziprasidone
Pipeline Intelligence
Ziprasidone: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 6 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
6FDA-linked events
Development evidence
NCT00044655Icahn School of Medicine at Mount Sinai · schizophreniaPHASE4
NCT00786318George Washington University · schizophreniaPHASE4
NCT01293825University Hospitals Cleveland Medical Center · bipolar_disorderPHASE4
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALZIPRASIDONE MESYLATE · 2019-12-26
FDA_APPROVALZIPRASIDONE HYDROCHLORIDE · 2017-08-22
FDA_APPROVALZIPRASIDONE HYDROCHLORIDE · 2017-02-17
FDA_APPROVALZIPRASIDONE HYDROCHLORIDE · 2013-10-10
FDA_APPROVALZIPRASIDONE HYDROCHLORIDE · 2012-09-05
FDA_APPROVALGEODON · 2001-02-05
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.